Immunologic vasculitis is a group of inflammatory autoimmune diseases, divided into primary and secondary. Clinical manifestations mainly depend on the type and size of the affected blood vessels and the organs involved, so there is no specificity; the principle of diagnosis and treatment of this disease is early diagnosis and early treatment, and the specific treatment mainly includes medication, surgery and so on. Immune vasculitis is a group of diseases characterized by inflammation and necrosis of blood vessel walls or perivascular tissues. Immune vasculitis is generally believed to be related to heredity, infection, immune system abnormalities and environmental factors. Depending on the type, size, location, and pathological characteristics of the affected vessels, it may produce corresponding clinical manifestations of inadequate blood supply to tissues and organs. Common systemic manifestations include fatigue, fever, joint and muscle pain, weight loss, etc. Skin involvement may result in rash; lung involvement may result in cough, sputum, hemoptysis, etc. Kidney involvement may result in proteinuria, hematuria, hypertension, renal insufficiency, etc.; and in severe cases, there may also be unconsciousness and coma. Immunological vasculitis patients need to improve the blood routine, blood sedimentation, C-reactive protein, blood biochemistry, anti-neutrophil cytoplasmic antibody, vascular CT, MRI, angiography and other related tests to clarify the diagnosis. Its treatment mainly includes drug therapy, such as prednisone and other glucocorticoid drugs; surgical treatment, such as endovascular stenting. It is recommended that patients with immune vasculitis should consult a doctor in time and follow the doctor’s instructions for standardized diagnosis and treatment.